[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Quick Uptakes
December 22/29, 1999

Globe-trotting Bacteria

Author Affiliations

Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999American Medical Association

JAMA. 1999;282(24):2291. doi:10.1001/jama.282.24.2291

First, the good news. During last month's Infectious Diseases Society of America meeting in Philadelphia, researchers from the University of Iowa reported promising findings on a new drug capable of fighting disease-causing bacteria that have become resistant to existing antibiotics.

The drug, a synthetic agent called linezolid, has demonstrated universal effectiveness against strains of staphylococci, enterococci, and streptococci organisms despite their patterns of resistance to other antibiotics. "One of the most exciting potential uses for this new agent is the management of resistant gram-positive infections," said Michael Pfaller, MD, professor of pathology and public health.